Back to Search Start Over

SP342A SINGLE 1000 MG INFUSION OF IRON ISOMALTOSIDE 1000 DEMONSTRATES A MORE RAPID HEMOGLOBIN RESPONSE AND REDUCED RISK OF CARDIO-VASCULAR ADVERSE EVENTS COMPARED TO MULTIPLE DOSES OF IV IRON SUCROSE IN THE FERWON TRIALS

Authors :
Lars L. Thomsen
Sunil Bhandari
Source :
Nephrology Dialysis Transplantation. 34
Publication Year :
2019
Publisher :
Oxford University Press (OUP), 2019.

Subjects

Subjects :
Transplantation
Reduced risk
Sucrose
business.industry
Pharmacology
Multiple dosing
Iron sucrose
chemistry.chemical_compound
chemistry
Nephrology
Infusion Procedure
Iron Isomaltoside 1000
medicine
Hemoglobin
business
Adverse effect
medicine.drug

Details

ISSN :
14602385 and 09310509
Volume :
34
Database :
OpenAIRE
Journal :
Nephrology Dialysis Transplantation
Accession number :
edsair.doi...........051e58c2c925e7c78b05e59579132561
Full Text :
https://doi.org/10.1093/ndt/gfz103.sp342
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details